Dear Congress Participants

Dear Readers of *The EPMA Journal*

Dear Friends around the world

Under the EPMA-Umbrella we make a great dream to become a reality: for the first time in the history of medical congresses, on September 15th till 18th 2011, representatives and delegations from more than 40 countries worldwide are coming together in Bonn, Germany, in order to summarise current achievements, discuss problems, create future strategies and celebrate our consolidation in the innovative field of preventive, predictive and personalised medicine.

***Congress venue:*Former Parliament of Federal Republic of Germany -- BUNDESTAG**

Platz der Vereinten Nationen 2, 53113 Bonn

The forum can be defined as an aureate brainstorming, since no one from the main stakeholders in the field is missing: global organisations, academia, international scientific associations, patient organisations, industry, patenting institutions, healthcare providers, policy makers, foundations, publishers, educators, regulating authorities, politicians, ministries of innovation, education and health, investors.

The mutual expectations are very high: all contributors understand well that preventive, predictive and personalised medicine is an extremely multidisciplinary field looking for innovation in science, healthcare and economy. Consequently, the overall successful concept as well as optimal approaches for its practical realisation can be hardly created by individual professional groups but also unlikely by single nations. The congress in Bonn is designed for both to discuss the strategic developments in the field generally and in its individual branches. However, independently from the global or subordinated scale, the main objectives remain the same, namely:Innovation and economy of PPPM-related approachesEducation at two levels A. professionals and B. general populationAppropriate research and grating programmesImplementing personalised medicine: practitioner and patient perspectivesTasks and perspectives for industry in the fieldCentral role of patient organisations to promote the participative medicine.

Chairmen, moderators, speakers, panellists will be requested to elaborate a summary of corresponding sessions that should include expert recommendations and points raised by panel discussions. The report will be sent to the national ministries of innovation, education and health as well as to the field-related global organisation for their further considerations in the field. The next milestone---EPMA-World Congress 2013---will update the achievements and demonstrate the efficacy of currently running and additionally triggered programmes in the field of predictive, preventive, personalised and participative medicine.

The EPMA-World Congress is an important global event promoting the consolidation and overall PPPM-concept as summarised above. This idea is expressed in the letter of support from the ***Organisation of United Nations*** and personally---by Mr. Sergei A. Ordzhonikidze, The Vice-Secretary-General of UNO:
